Identification of a risk factor for clozapine-induced sialorrhea

Identification of a risk factor for clozapine-induced sialorrhea - Identification of a risk factor for CIS

Status

Active, not recruiting

Phases

Unknown

Study type

Observational

Source

JPRN

Registry ID

JPRN-UMIN000026822

Enrollment

Registered

2017-04-01

Start date

2017-05-01

Completion date

Unknown

Last updated

2026-06-29

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

schizophrenia

Interventions

None listed

Eligibility

Sex/Gender

All

Inclusion criteria

Inclusion criteria: Patient taking clozapine

Exclusion criteria

Exclusion criteria: Patient changing dosage of clozapine

Design outcomes

Primary

Measure	Time frame
this study evaluates the association between the blood concentration of clozapine and metabolite and Drooling Severity and Drooling Frequency Scale.	—

Secondary

Measure	Time frame
this study evaluates the association between the dysphagia, extrapyramidal symptom and Drooling Severity and Drooling Frequency Scale.	—

Countries

Japan

Contacts

Public ContactShuhei Ishikawa

Hokkaido University Hospital department of pharmacy

s-ishikawa@huhp.hokudai.ac.jp011-716-1161

Outcome results